Huseyin Mertsoylu

7PUBLICATIONS
11CO-AUTHORS
Tumour immunologyRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 08, 2024
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.

Efsun Somay, Busra Yilmaz, Erkan Topkan

|Sep 27, 2024
Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study.

Erkan Topkan, Efsun Somay, Ali Ayberk Besen

|Jan 22, 2024
The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.

Efsun Somay, Erkan Topkan, Umur Anil Pehlivan

|Apr 21, 2022
High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients.

Ahmet Kucuk, Erkan Topkan, Ugur Selek

|Aug 18, 2020
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.

Erkan Topkan, Huseyin Mertsoylu, Ahmet Kucuk

|Jun 23, 2020
Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide.

Erkan Topkan, Ali A Besen, Huseyin Mertsoylu

Pageof 2

Frequent Collaborators

7 joint publications

Erkan Topkan

6 joint publications

Ugur Selek

4 joint publications

Ali Ayberk Besen

3 joint publications

Ahmet Kucuk